The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Eluting Balloon for Peripheral Artery Disease Market Research Report 2025
Synopsis
A drug eluting balloon is a semi-compliant angioplasty balloon that is surrounded by an anti-proliferative medicine. The medicine is ejected to the vessel wall during the inflation of the balloon. The active substance of the balloon is highly lipophilic (dissolved in lipids or fats). The drug eluting balloon homogeneously delivers the drug to the vessel and provides treatment for peripheral artery disease.
The global Drug Eluting Balloon for Peripheral Artery Disease market was valued at US$ 315.4 million in 2023 and is anticipated to reach US$ 441.6 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloon for Peripheral Artery Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloon for Peripheral Artery Disease.
Report Scope
The Drug Eluting Balloon for Peripheral Artery Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Balloon for Peripheral Artery Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloon for Peripheral Artery Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cook Group
BD
Medtronic
Bayer
Opto Circuits
Segment by Type
3μg/ mm2
2μg/ mm2
Others
Segment by Application
Hospitals
Ambulatory Surgery Centers
Catheterization Laboratories
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloon for Peripheral Artery Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloon for Peripheral Artery Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A drug eluting balloon is a semi-compliant angioplasty balloon that is surrounded by an anti-proliferative medicine. The medicine is ejected to the vessel wall during the inflation of the balloon. The active substance of the balloon is highly lipophilic (dissolved in lipids or fats). The drug eluting balloon homogeneously delivers the drug to the vessel and provides treatment for peripheral artery disease.
The global Drug Eluting Balloon for Peripheral Artery Disease market was valued at US$ 315.4 million in 2023 and is anticipated to reach US$ 441.6 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloon for Peripheral Artery Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloon for Peripheral Artery Disease.
Report Scope
The Drug Eluting Balloon for Peripheral Artery Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Balloon for Peripheral Artery Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloon for Peripheral Artery Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cook Group
BD
Medtronic
Bayer
Opto Circuits
Segment by Type
3μg/ mm2
2μg/ mm2
Others
Segment by Application
Hospitals
Ambulatory Surgery Centers
Catheterization Laboratories
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloon for Peripheral Artery Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloon for Peripheral Artery Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drug Eluting Balloon for Peripheral Artery Disease Market Overview
1.1 Product Overview and Scope of Drug Eluting Balloon for Peripheral Artery Disease
1.2 Drug Eluting Balloon for Peripheral Artery Disease Segment by Type
1.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Type (2024-2030)
1.2.2 3μg/ mm2
1.2.3 2μg/ mm2
1.2.4 Others
1.3 Drug Eluting Balloon for Peripheral Artery Disease Segment by Application
1.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centers
1.3.4 Catheterization Laboratories
1.3.5 Others
1.4 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue 2019-2030
1.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales 2019-2030
1.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Balloon for Peripheral Artery Disease Market Competition by Manufacturers
2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturers (2019-2024)
2.4 Global Drug Eluting Balloon for Peripheral Artery Disease Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Product Type & Application
2.7 Drug Eluting Balloon for Peripheral Artery Disease Market Competitive Situation and Trends
2.7.1 Drug Eluting Balloon for Peripheral Artery Disease Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Balloon for Peripheral Artery Disease Players Market Share by Revenue
2.7.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Balloon for Peripheral Artery Disease Retrospective Market Scenario by Region
3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2025-2030
3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2025-2030
3.4 North America Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.4.1 North America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cook Group
6.1.1 Cook Group Corporation Information
6.1.2 Cook Group Description and Business Overview
6.1.3 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.1.5 Cook Group Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Opto Circuits
6.5.1 Opto Circuits Corporation Information
6.5.2 Opto Circuits Description and Business Overview
6.5.3 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.5.5 Opto Circuits Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Chain Analysis
7.2 Drug Eluting Balloon for Peripheral Artery Disease Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Balloon for Peripheral Artery Disease Production Mode & Process
7.4 Drug Eluting Balloon for Peripheral Artery Disease Sales and Marketing
7.4.1 Drug Eluting Balloon for Peripheral Artery Disease Sales Channels
7.4.2 Drug Eluting Balloon for Peripheral Artery Disease Distributors
7.5 Drug Eluting Balloon for Peripheral Artery Disease Customers
8 Drug Eluting Balloon for Peripheral Artery Disease Market Dynamics
8.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Trends
8.2 Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
8.3 Drug Eluting Balloon for Peripheral Artery Disease Market Challenges
8.4 Drug Eluting Balloon for Peripheral Artery Disease Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drug Eluting Balloon for Peripheral Artery Disease Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drug Eluting Balloon for Peripheral Artery Disease Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drug Eluting Balloon for Peripheral Artery Disease, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Product Type & Application
Table 12. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Balloon for Peripheral Artery Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Balloon for Peripheral Artery Disease as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2019-2024) & (K Units)
Table 18. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2019-2024)
Table 19. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2025-2030) & (K Units)
Table 20. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2025-2030)
Table 21. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2019-2024)
Table 23. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2025-2030)
Table 25. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2024) & (K Units)
Table 27. North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2025-2030) & (K Units)
Table 28. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2019-2024)
Table 51. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2025-2030)
Table 52. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2019-2024)
Table 53. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2025-2030)
Table 54. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2019-2024)
Table 57. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2025-2030)
Table 58. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2019-2024)
Table 59. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2025-2030)
Table 60. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2019-2024)
Table 61. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2025-2030)
Table 62. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2019-2024)
Table 63. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2025-2030)
Table 64. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2019-2024)
Table 67. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2025-2030)
Table 68. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2019-2024)
Table 69. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2025-2030)
Table 70. Cook Group Corporation Information
Table 71. Cook Group Description and Business Overview
Table 72. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Product
Table 74. Cook Group Recent Developments/Updates
Table 75. BD Corporation Information
Table 76. BD Description and Business Overview
Table 77. BD Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. BD Drug Eluting Balloon for Peripheral Artery Disease Product
Table 79. BD Recent Developments/Updates
Table 80. Medtronic Corporation Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Bayer Drug Eluting Balloon for Peripheral Artery Disease Product
Table 89. Bayer Recent Developments/Updates
Table 90. Opto Circuits Corporation Information
Table 91. Opto Circuits Description and Business Overview
Table 92. Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Product
Table 94. Opto Circuits Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Drug Eluting Balloon for Peripheral Artery Disease Distributors List
Table 98. Drug Eluting Balloon for Peripheral Artery Disease Customers List
Table 99. Drug Eluting Balloon for Peripheral Artery Disease Market Trends
Table 100. Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
Table 101. Drug Eluting Balloon for Peripheral Artery Disease Market Challenges
Table 102. Drug Eluting Balloon for Peripheral Artery Disease Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Eluting Balloon for Peripheral Artery Disease
Figure 2. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Type in 2023 & 2030
Figure 4. 3μg/ mm2 Product Picture
Figure 5. 2μg/ mm2 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Ambulatory Surgery Centers
Figure 11. Catheterization Laboratories
Figure 12. Others
Figure 13. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size (2019-2030) & (US$ Million)
Figure 15. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (2019-2030) & (K Units)
Figure 16. Global Drug Eluting Balloon for Peripheral Artery Disease Average Price (USD/Unit) & (2019-2030)
Figure 17. Drug Eluting Balloon for Peripheral Artery Disease Report Years Considered
Figure 18. Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Manufacturers in 2023
Figure 19. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Drug Eluting Balloon for Peripheral Artery Disease Players: Market Share by Revenue in 2023
Figure 21. Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2019-2030)
Figure 24. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2019-2030)
Figure 28. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2019-2030)
Figure 29. Germany Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2019-2030)
Figure 36. China Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2019-2030)
Figure 47. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Type (2019-2030)
Figure 57. Global Revenue Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Type (2019-2030)
Figure 58. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Application (2019-2030)
Figure 60. Global Revenue Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Application (2019-2030)
Figure 61. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2019-2030)
Figure 62. Drug Eluting Balloon for Peripheral Artery Disease Value Chain
Figure 63. Drug Eluting Balloon for Peripheral Artery Disease Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
